Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Aarhus Universitet Forside
Hjælp og OSS
English
Dansk
Forside
Profiler
Forskningsenheder
Projekter
Publikation
Priser
Aktiviteter
Kurser
Presse/medier
Søg efter ekspertise, navn eller tilknytning
Jan Krog
Ekstern VIP
,
Institut for Klinisk Medicin - Bedøvelse og Operation, Intensiv
Klinisk lektor
,
Institut for Klinisk Medicin - Bedøvelse og Operation, Intensiv
E-mail
jan.krog
clin.au
dk
Palle Juul-Jensens Boulevard 35
8200
Aarhus N
Danmark
1999
2023
Publikationer pr. år
Vis
Fingeraftryk
Netværk
Publikation
(35)
Aktiviteter
(3)
Lignende profiler
(6)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Jan Krog er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Medicine and Dentistry
Randomized Controlled Trial
100%
Digestive System Surgery
100%
Orthopedic Surgery
100%
Biological Marker
56%
Streptococcus Group A
50%
Symptom
50%
Cardiovascular Disease
50%
Peroperative Complication
50%
Noncardiac Surgery
50%
Hemodynamic
50%
Heart Disease
50%
Odds Ratio
50%
Decision Making
50%
Heliox
50%
Day of Surgery
50%
COVID-19
50%
Tranexamic Acid
50%
Craniofacial Surgery
50%
Neuraxial Anesthesia
50%
Acetylsalicylic Acid
50%
Hospital Cost
50%
Prospective Study
50%
Sepsis
25%
Group A Streptococcal Infection
25%
Puerperal Infection
25%
Multiple Organ Dysfunction Syndrome
25%
Antibiotics
25%
Differential Diagnosis
25%
Infection
25%
Placebo
18%
Craniofacial Synostosis
18%
Bleeding
12%
Drug Dose Regimen
6%
Infusion
6%
Continuous Infusion
6%
Blood Transfusion
6%
Low Drug Dose
6%
Surgical Stress
6%
Placebo-Controlled Study
6%
Immunology and Microbiology
Inflammation Response
75%
Monocyte
50%
Natural Killer Cell
50%
NKG2D
50%
CD14
50%
Heliox
50%
Antiinflammatory Activity
50%
Signal-Regulatory Protein Alpha
50%
Acute Inflammation
50%
Spinal Cord
50%
Interleukin-6
20%
TLR4
20%
Cytokine
18%
Interleukin 6
15%
Tumor Necrosis Factor
12%
Medline
12%
Low Drug Dose
12%
Inflammatory Arthritis
12%
C-Reactive Protein
12%
VLA-4
12%
Embase
12%
Cerebrospinal Fluid
11%
Interleukin-1
10%
Innate Immune System
10%
Adaptive Immune System
10%
Blood Level
10%
Normal Human
10%
Mediator
10%
Cell Surface
10%
Prognostic Biomarker
10%
Surface Property
10%
Immunocompetent Cell
5%
Interleukin 8
5%
Pharmacology, Toxicology and Pharmaceutical Science
Tranexamic Acid
100%
Biological Marker
66%
Inflammation
56%
Spinal Cord Injury
50%
Glial Fibrillary Acidic Protein
50%
Antiinflammatory Activity
50%
Acid Protein
28%
Puerperal Infection
25%
Craniofacial Synostosis
22%
Interferon
21%
Bleeding
19%
Placebo
18%
Injury Severity
14%
Interleukin 4
14%
Interleukin 12p70
14%
Tumor Necrosis Factor
14%
Interleukin 13
14%
Interleukin 10
14%
Neuron Specific Enolase
14%
Interleukin 2
14%
Interleukin 6
10%
Lipopolysaccharide-Induced Inflammation
9%
Spine Injury
7%
Interleukin 8
7%
Interleukin 1
7%
Placebo-Controlled Study
6%
